Dossier
Merck KGaA
Coverage of Merck KGaA in the Nexus archive.
- Germany's Merck KGaA is buying lab-tools supplier Bio-Techne for $11.3 billion
Germany's Merck KGaA is acquiring lab-tools supplier Bio-Techne for $11.3 billion, marking its largest deal since the Sigma-Aldrich buyout. The acquisition expands Merck's presence in proteins, spatial biology, and cell and gene therapy.
- European Stocks Bounce Back as Merck KGaA and ASML Advance
European stocks rebounded as Merck KGaA and ASML shares advanced, indicating a positive trend in the market. This upswing suggests investor confidence is returning. The gains were led by these two companies.